The Dynamics of Heparin-Binding Protein in Cardiothoracic Surgery-A Pilot Study.

biomarker cardiopulmonary bypass cardiothoracic surgery heparin-binding protein postoperative infections

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
09 2021
Historique:
received: 01 10 2020
revised: 16 12 2020
accepted: 18 12 2020
pubmed: 18 1 2021
medline: 26 10 2021
entrez: 17 1 2021
Statut: ppublish

Résumé

To explore the preoperative, intraoperative, and postoperative dynamics of heparin-binding protein (HBP) in cardiothoracic surgery. This was a prospective, observational study. The study was conducted at a single university hospital. Thirty patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) were included, 15 of whom underwent coronary artery bypass grafting surgery and 15 of whom underwent complex procedures. Ten patients undergoing lung surgery also were included as a conventional surgery reference group. No interventions were performed. HBP was measured at nine different perioperative times. HBP levels increased immediately after heparin administration, further increased during CPB, but decreased rapidly after protamine administration. At arrival to the intensive care unit, median HBP levels were 24.8 (15.6-38.1) ng/mL for coronary artery bypass grafting patients and 51.2 (34.0-117.7) ng/mL for complex surgery patients (p = 0.011). One day after surgery, HBP levels in all three groups were below the proposed cutoff of 30 ng/mL, which previously was found to predict development of organ dysfunction in patients with infection. HBP levels are elevated by the administration of heparin and the use of CPB but reduced by protamine administration. At postoperative day one, HBP levels were less than the threshold for organ dysfunction in patients with infection. The usefulness of HBP for predicting postoperative infections in cardiothoracic surgery should be investigated in future studies.

Identifiants

pubmed: 33454168
pii: S1053-0770(20)31380-X
doi: 10.1053/j.jvca.2020.12.033
pii:
doi:

Substances chimiques

AZU1 protein, human 0
Antimicrobial Cationic Peptides 0
Blood Proteins 0
Heparin 9005-49-6

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2640-2650

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Niklas Sterner (N)

Department of Cardiothoracic Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Jane Fisher (J)

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.

Louise Thelaus (L)

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.

Carolin Ketteler (C)

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.

Špela Lemež (Š)

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.

Alain Dardashti (A)

Department of Cardiothoracic Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Johan Nilsson (J)

Department of Cardiothoracic Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Adam Linder (A)

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.

Igor Zindovic (I)

Department of Cardiothoracic Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden. Electronic address: igor.zindovic@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH